{
  "question_stem": {
    "en": "A 4-week-old boy is being evaluated in the neonatal intensive care unit. The patient was born at 29 weeks gestation. Immediately before delivery, the mother received a dose of terbutaline in an attempt to stop the contractions and a dose of antenatal corticosteroids to help improve fetal lung maturity. Shortly after birth, the patient developed severe respiratory distress, requiring surfactant administration and supplemental oxygen. He was weaned off oxygen therapy after a week. The patient also received routine prophylactic medications, including erythromycin ophthalmic ointment and intramuscular vitamin K, at birth. Ophthalmic examination today shows abnormal retinal vascularization that extends into the vitreous. The retinal findings in this patient are most likely related to which of the following?",
    "zh": "一名 4 周大的男婴正在新生儿重症监护病房接受评估。该患者出生时孕龄为 29 周。在分娩前，母亲接受了一剂特布他林以试图阻止宫缩，以及一剂产前皮质类固醇以帮助改善胎儿肺部成熟度。出生后不久，患者出现严重的呼吸窘迫，需要使用表面活性剂和补充氧气。一周后他停止了氧疗。该患者在出生时还接受了常规的预防性药物，包括红霉素眼药膏和肌内注射维生素 K。今天的眼科检查显示视网膜血管异常，延伸至玻璃体。该患者的视网膜表现最可能与以下哪一项有关？"
  },
  "question": {
    "en": "The retinal findings in this patient are most likely related to which of the following?",
    "zh": "该患者的视网膜表现最可能与以下哪一项有关？"
  },
  "options": {
    "A": {
      "en": "Maternal corticosteroid therapy",
      "zh": "母亲皮质类固醇治疗"
    },
    "B": {
      "en": "Maternal terbutaline treatment",
      "zh": "母亲特布他林治疗"
    },
    "C": {
      "en": "Neonatal ophthalmic antibiotic treatment",
      "zh": "新生儿眼部抗生素治疗"
    },
    "D": {
      "en": "Neonatal oxygen supplementation",
      "zh": "新生儿氧气补充"
    },
    "E": {
      "en": "Neonatal surfactant therapy",
      "zh": "新生儿表面活性剂治疗"
    }
  },
  "correct_answer": "D",
  "explanation": {
    "en": "This infant born at 29 weeks gestation has abnormal retinal vascularization extending into the vitreous, findings indicative of retinopathy of prematurity (ROP). This condition, exclusive to premature neonates, is a leading cause of severe visual impairment and blindness.\n\nIn utero, the relatively low oxygen tension normally causes upregulation of proangiogenic factors, such as vascular endothelial growth factor (VEGF); these growth factors stimulate normal vessel growth. Premature birth disrupts this process as follows:\n\n*   The relatively hyperoxic environment (even in room air) after delivery leads to downregulation of VEGF and slowing or arrest of retinal vascular growth.\n*   Once the retina begins to mature (over subsequent weeks), increased metabolic demand causes relative retinal hypoxia, which again stimulates VEGF. This often results in aberrant new vessel formation (neovascularization), which can lead to retinal scarring and/or detachment if severe.\n\nAlthough prematurity alone can lead to ROP, the risk is increased in premature neonates with significantly ELEVATED ARTERIAL OXYGEN TENSION because hyperoxia exacerbates the initial VEGF suppression and increases risk of subsequent aberrant neovascularization. In this case, the patient had neonatal respiratory distress syndrome and received supplemental oxygen, which likely contributed to disrupted retinal angiogenesis.\n\n(Choice A) Corticosteroids are often administered to women in preterm labor to induce surfactant production by the fetal lungs and decrease the risk or severity of neonatal respiratory distress syndrome. This therapy is not associated with neonatal retinal neovascularization.\n\n(Choice B) Terbutaline is a beta agonist used to delay preterm labor and delivery by suppressing uterine contractions. Fetal risks include tachycardia and hypoglycemia (due to maternal hyperglycemia causing fetal hyperinsulinism), not ROP.\n\n(Choice C) Neonatal ophthalmic antibiotic treatment (ie, erythromycin) prevents gonococcal conjunctivitis and can cause chemical conjunctivitis in rare cases; however, retinal changes would not occur.\n\n(Choice E) Exogenous surfactant decreases alveolar surface tension and alveolar collapse (ie, atelectasis), improving ventilation/perfusion mismatch. This therapy allows for supplementation of oxygen at decreased concentrations, which helps prevent ROP.\n\nEducational objective:\nThe pathogenesis of retinopathy of prematurity involves an initial downregulation of proangiogenic factors (eg, VEGF) due to hyperoxia following delivery. Subsequently, increased metabolic demand causes relative retinal hypoxia, which stimulates a pathological increase in VEGF leading to aberrant vessel formation. Neonatal oxygen supplementation increases the risk in premature infants.",
    "zh": "这名孕龄为 29 周出生的婴儿出现视网膜血管异常，延伸至玻璃体，提示早产儿视网膜病变 (ROP)。这种情况仅限于早产新生儿，是导致严重视力损害和失明的主要原因。\n\n在子宫内，相对较低的氧分压通常会导致促血管生成因子的上调，例如血管内皮生长因子 (VEGF)；这些生长因子刺激正常的血管生长。早产会破坏此过程，如下所示：\n\n*   出生后相对高氧环境（即使在室内空气中）会导致 VEGF 下调，并减缓或阻止视网膜血管生长。\n*   一旦视网膜开始成熟（在随后的几周内），新陈代谢的需求增加会导致相对的视网膜缺氧，这又会刺激 VEGF。这通常会导致异常的新血管形成（新生血管形成），如果严重，可能导致视网膜瘢痕形成和/或脱离。\n\n尽管仅早产就可能导致 ROP，但在动脉氧分压显著升高的早产新生儿中，风险会增加，因为高氧血症会加剧最初的 VEGF 抑制，并增加随后异常新生血管形成的风险。在这种情况下，患者患有新生儿呼吸窘迫综合征，并接受了补充氧气，这可能导致视网膜血管生成的破坏。\n\n（选项 A）皮质类固醇通常用于早产的妇女，以诱导胎儿肺部产生表面活性剂，并降低新生儿呼吸窘迫综合征的风险或严重程度。这种治疗与新生儿视网膜新生血管形成无关。\n\n（选项 B）特布他林是一种 β 受体激动剂，通过抑制子宫收缩来延迟早产和分娩。胎儿的风险包括心动过速和低血糖症（由于母亲高血糖症导致胎儿高胰岛素血症），而非 ROP。\n\n（选项 C）新生儿眼部抗生素治疗（即红霉素）可预防淋病性结膜炎，在极少数情况下可引起化学性结膜炎；但是，视网膜变化不会发生。\n\n（选项 E）外源性表面活性剂降低肺泡表面张力和肺泡塌陷（即肺不张），改善通气/灌注失调。这种治疗允许以较低的浓度补充氧气，这有助于预防 ROP。\n\n教育目标：\n早产儿视网膜病变的病理生理学涉及由于分娩后高氧血症导致促血管生成因子（例如 VEGF）的最初下调。随后，增加的新陈代谢需求导致相对的视网膜缺氧，这刺激了 VEGF 的病理性增加，从而导致异常的血管形成。新生儿氧气补充会增加早产儿的风险。"
  },
  "summary": {
    "en": "This question tests the understanding of the pathogenesis and risk factors for retinopathy of prematurity (ROP) in premature infants. It specifically assesses the link between neonatal oxygen supplementation and the development of abnormal retinal vascularization.\n\nTo solve this question, one must recognize the clinical presentation of ROP and recall its pathophysiology, particularly the role of oxygen levels in regulating VEGF and neovascularization. Differentiating this from other potential causes or treatments mentioned in the vignette is crucial.",
    "zh": "这个问题考察了对早产儿早产儿视网膜病变 (ROP) 的发病机制和危险因素的理解。它特别评估了新生儿氧气补充与异常视网膜血管生成之间的联系。\n\n要解决这个问题，必须认识到 ROP 的临床表现并回忆其病理生理学，特别是氧水平在调节 VEGF 和新生血管形成中的作用。将其与其他潜在原因或短文中所述的治疗方法区分开来至关重要。"
  },
  "tags": "Retinopathy of prematurity; Neonatal care; Ophthalmology; Oxygen therapy; VEGF; Neovascularization; Prematurity; Retinal vascularization",
  "category": "Ophthalmology",
  "question_id": "799",
  "has_exhibits": true,
  "exhibit_count": 1,
  "exhibit_files": [
    "image1.jpg"
  ],
  "folder_path": "C:\\Datas\\usmle\\step1\\clip\\Ophthalmology 23\\799",
  "extracted_at": "2025-11-05T19:43:19.332372",
  "extraction_config": {
    "temperature": 0.1,
    "top_k": 2,
    "prompt_strategy": "standard"
  },
  "translated_at": "2025-11-07T18:45:00.023989",
  "translation_model": "gemini-2.0-flash-lite",
  "embedding_model": "models/embedding-001",
  "embedding_dimension": 768
}